The global frontotemporal dementia therapeutics market is witnessing significant growth. This trend can be linked to a rising prevalence of frontotemporal dementia, coupled with advancements in research and manufacture of novel medications. The market is stimulated by a combination of factors, including an senior population, increasing healthcare i